Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week

DUBLIN, May 1, 2026 /PRNewswire/ -- Keenova Therapeutics plc announced today that a new presentation on hepatorenal syndrome-acute kidney injury (HRS‑AKI) and TERLIVAZ® (terlipressin) will be shared at Digestive Disease Week (DDW), taking place May 2-5, 2026. "We are pleased to share...

Read More